Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

1. Bamias, A.
2. Davis, I.D.
3. Galsky, M.D.
4. Arranz, J.Á.
5. Kikuchi, E.
6. Grande, E.
7. del Muro, X.G.
8. Park, S.H.
9. De Giorgi, U.
10. Alekseev, B.
11. Mencinger, M.
12. Izumi, K.
13. Schutz, F.A.
14. Puente, J.
15. Li, J.-R.
16. Panni, S.
17. Gumus, M.
18. Özgüroğlu, M.
19. Mariathasan, S.
20. Poloz, Y.
21. Bene-Tchaleu, F.
22. Lee, C.
23. Bernhard, S.
24. De Santis, M.